VICTRELIS (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the VICTRELIS drug offered from Merck Sharp & Dohme Corp.. This HCV NS3/4A Protease Inhibitors [MoA],Hepatitis C Virus NS3/4A Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A5 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | BOCEPREVIR |
| SUBSTANCE NAME: | BOCEPREVIR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | HCV NS3/4A Protease Inhibitors [MoA],Hepatitis C Virus NS3/4A Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A5 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-05-13 |
| END MARKETING DATE: | 0000-00-00 |
VICTRELIS HUMAN PRESCRIPTION DRUG Details:
| Item Description | VICTRELIS from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/1) |
| START MARKETING DATE: | 2011-05-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0085-0314_76cb8796-a942-447d-856d-00ef93749ed9 |
| PRODUCT NDC: | 0085-0314 |
| APPLICATION NUMBER: | NDA202258 |
Other BOCEPREVIR Pharmaceutical Manufacturers / Labelers:
